Skip to Main Content Menu Search Site

Cell-Free Biomolecule Manufacturing

A low-cost, portable method for creating vaccines, therapeutics, and diagnostics on demand

Wyss Institute researchers have developed a biomolecular manufacturing method that can quickly and easily produce a wide range of vaccines, antimicrobial peptides and antibody conjugates while doing so anywhere, even in places without access to electrical power or refrigeration.

The breakthrough could provide a life-saving workaround for making modern interventions available in remote areas. Today many field clinics around the world lack access to a “cold chain” of refrigeration that vaccines and other biomolecules typically require from the time of synthesis to administration. But using the Institute’s portable biomolecular manufacturing kit, clinicians could simply add water to pre-packaged, freeze-dried pellets in order to produce a wide array of active biomolecules.

The ability to synthesize and administer biomolecular compounds, anywhere, could undoubtedly shift the reach of medicine and science across the world.

James Collins

The method works by embedding cell-free “machinery” and DNA instructions inside two kinds of freeze-dried pellets, one that contains the synthesis machinery and the other that can be customized to instruct production of a wide range of final products. The freeze-dried pellets are extremely stable and could be stored at room temperature for a year or potentially longer. If a vaccine or other type of biomolecular product was needed in the field, the portable manufacturing process would only require the appropriate pellets to be combined and rehydrated with water.

This technology is available for licensing.

To obtain additional information or to learn more about our intellectual property portfolio or licensing opportunities, please contact us.

Get in touch

Close menu